COVID-19 in Patients with Chronic Lung Disease - 19/04/23
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Résumé |
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus that causes an acute respiratory tract infection known as coronavirus disease 2019 (COVID-19). SARS-CoV-2 enters cells by binding the ACE2 receptor and coreceptors notably TMPRSS2 or Cathepsin L. Severe COVID-19 infection can lead to acute lung injury. Below we describe the current evidence of the impact of common chronic lung diseases (CLDs) on the development of COVID-19. The impact of treatment of CLD on COVID-19 and any risk of vaccination in patients with CLD are considered.
Le texte complet de cet article est disponible en PDF.Keywords : Chronic lung disease, Asthma, COPD, Cystic fibrosis, Interstitial lung disease, Pulmonary arterial hypertension, COVID-19 susceptibility, Vaccination
Plan
Vol 44 - N° 2
P. 385-393 - juin 2023 Retour au numéro
Article précédent
- Coronavirus Disease-2019 in Pregnancy
- Jose Rojas-Suarez, Jezid Miranda
- Coronavirus Disease-2019 in the Immunocompromised Host
- Christopher D. Bertini, Fareed Khawaja, Ajay Sheshadri
Bienvenue sur EM-consulte, la référence des professionnels de santé.